.6
| Name | Date | Number of Shares | Transaction | Price/Share | Footnote | |||||||||||||||
| 667, L.P. | 1/17/2025 | 682 | Purchase | 6.5556 | 1 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/17/2025 | 7,441 | Purchase | 6.5556 | 1 | |||||||||||||||
| 667, L.P. | 1/21/2025 | 369 | Purchase | 6.6330 | 2 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/21/2025 | 4,031 | Purchase | 6.6330 | 2 | |||||||||||||||
| 667, L.P. | 1/22/2025 | 428 | Purchase | 6.5970 | 3 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/22/2025 | 4,672 | Purchase | 6.5970 | 3 | |||||||||||||||
| 667, L.P. | 1/23/2025 | 1,121 | Purchase | 6.4293 | 4 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/23/2025 | 12,239 | Purchase | 6.4293 | 4 | |||||||||||||||
| 667, L.P. | 1/24/2025 | 8 | Purchase | 6.4500 | ||||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/24/2025 | 92 | Purchase | 6.4500 | ||||||||||||||||
| 667, L.P. | 1/24/2025 | 1,219 | Purchase | 6.5581 | 5 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/24/2025 | 13,315 | Purchase | 6.5581 | 5 | |||||||||||||||
| 667, L.P. | 1/27/2025 | 317 | Purchase | 6.2408 | 6 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/27/2025 | 3,451 | Purchase | 6.2408 | 6 | |||||||||||||||
| 667, L.P. | 1/28/2025 | 51 | Purchase | 6.1200 | ||||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/28/2025 | 559 | Purchase | 6.1200 | ||||||||||||||||
| 667, L.P. | 1/30/2025 | 188 | Purchase | 6.5000 | ||||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/30/2025 | 2,054 | Purchase | 6.5000 | ||||||||||||||||
| 667, L.P. | 1/31/2025 | 810 | Purchase | 6.5016 | 7 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/31/2025 | 8,824 | Purchase | 6.5016 | 7 | |||||||||||||||
| 667, L.P. | 1/31/2025 | 134 | Purchase | 6.5400 | 8 | |||||||||||||||
| Baker Brothers Life Sciences, L.P. | 1/31/2025 | 1,466 | Purchase | 6.5400 | 8 | |||||||||||||||
| 667, L.P. | 2/3/2025 | 25 | Purchase | 6.4400 | ||||||||||||||||
| Baker Brothers Life Sciences, L.P. | 2/3/2025 | 275 | Purchase | 6.4400 | ||||||||||||||||
(1) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.51 to $6.68. The Reporting Persons undertake to provide the staff of the Securities and Exchange Commission (the “Staff”), upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(2) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.59 to $6.67. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(3) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.52 to $6.64. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(4) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.26 to $6.51. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(5) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.52 to $6.60. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(6) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.17 to $6.37. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(7) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.49 to $6.51. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.
(8) The reported price is a weighted average price. These shares were traded in multiple transactions at prices ranging from $6.54 to $6.55. The Reporting Persons undertake to provide the Staff, upon request, full information regarding the number of shares traded at each separate price within the ranges set forth in this footnote.